| Followers | 19 |
| Posts | 6542 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Friday, August 23, 2019 11:20:59 AM
Come on Maxwell, why would the Wolf suggest that when the MM’s can simply use Pig Latin instead you understand. Here is a link that JT from CVSY has communicated to the Wolf via Telepathy or Cut and Paste signals to place on the IHub cap forum you understand. Have Mercy Wolf ahooooooo
There are a few things that you need to know about the market maker NITE. Knight Securities uses the ticker $NITE. This market maker is known for being one of the most abusive market makers in the penny stock market..........
http://www.penny-stock-brokers.org/mm-nite-shorting/
Maxwell Said;
https://www.ispot.tv/ad/7DT8/geico-pig-latin-maxwell-pig
There are a few things that you need to know about the market maker NITE. Knight Securities uses the ticker $NITE. This market maker is known for being one of the most abusive market makers in the penny stock market..........
http://www.penny-stock-brokers.org/mm-nite-shorting/
Maxwell Said;
https://www.ispot.tv/ad/7DT8/geico-pig-latin-maxwell-pig
Recent CVSI News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
